Literature DB >> 1974371

Further heterogeneity of the beta-adrenoceptor. The phenylethanolaminotetralines: new selective agonists for atypical beta-adrenoceptors.

L Manara1, A Bianchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1974371     DOI： 10.1016/0165-6147(90)90247-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  8 in total

1.  Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.

Authors:  M Bardou; C Loustalot; J Cortijo; B Simon; E Naline; M Dumas; S Esteve; T Croci; P Chalon; R Frydman; P Sagot; L Manara; E J Morcillo; C Advenier
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Functional beta3-adrenoceptor in the human heart.

Authors:  C Gauthier; G Tavernier; F Charpentier; D Langin; H Le Marec
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

3.  Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.

Authors:  S J Roberts; P Molenaar; R J Summers
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.

Authors:  C Rouget; M Breuiller-Fouché; F J Mercier; M J Leroy; C Loustalot; E Naline; R Frydman; T Croci; E J Morcillo; C Advenier; M Bardou
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

5.  Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.

Authors:  N Blin; C Nahmias; M F Drumare; A D Strosberg
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

6.  The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.

Authors:  C Pott; K Brixius; A Bundkirchen; B Bölck; W Bloch; D Steinritz; U Mehlhorn; R H G Schwinger
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

7.  Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes.

Authors:  C Nahmias; N Blin; J M Elalouf; M G Mattei; A D Strosberg; L J Emorine
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

8.  Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles.

Authors:  Marcos Lorca; Cesar Morales-Verdejo; David Vásquez-Velásquez; Juan Andrades-Lagos; Javier Campanini-Salinas; Jorge Soto-Delgado; Gonzalo Recabarren-Gajardo; Jaime Mella
Journal:  Molecules       Date:  2018-05-16       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.